Literature DB >> 18816734

Is the Th1/Th2 paradigm of immune regulation applicable to IBD?

Ivan J Fuss1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18816734     DOI： 10.1002/ibd.20683

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  23 in total

1.  The role of the immune system in regulating the microbiota.

Authors:  Benjamin P Willing; Navkiran Gill; B Brett Finlay
Journal:  Gut Microbes       Date:  2010-03-04

Review 2.  The regulation of thymic stromal lymphopoietin in gut immune homeostasis.

Authors:  Ming Li; Ji Zhang; Yuzhang Wu; Jintao Li
Journal:  Dig Dis Sci       Date:  2011-02-12       Impact factor: 3.199

Review 3.  Protein kinases are potential targets to treat inflammatory bowel disease.

Authors:  Lei Yang; Yutao Yan
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-11-06

Review 4.  Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease.

Authors:  Raghavan Chinnadurai; Spencer Ng; Vijayakumar Velu; Jacques Galipeau
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

5.  Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?

Authors:  Fabiany da Costa Gonçalves; Natália Schneider; Fernanda Otesbelgue Pinto; Fabíola Schons Meyer; Fernanda Visioli; Bianca Pfaffenseller; Patrícia Luciana da Costa Lopez; Eduardo Pandolfi Passos; Elizabeth Obino Cirne-Lima; Luíse Meurer; Ana Helena Paz
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

6.  Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease.

Authors:  Wenyu Jiang; Jiewen Su; Xiaofei Zhang; Xiuqin Cheng; Jun Zhou; Ruihua Shi; Hongjie Zhang
Journal:  Inflamm Res       Date:  2014-08-18       Impact factor: 4.575

7.  Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice.

Authors:  Jun Yao; Cheng Wei; Jian-Yao Wang; Ru Zhang; Ying-Xue Li; Li-Sheng Wang
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

8.  Regulation of eotaxin-3/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblasts.

Authors:  K Takahashi; H Imaeda; T Fujimoto; H Ban; S Bamba; T Tsujikawa; M Sasaki; Y Fujiyama; A Andoh
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

9.  Epigallocatechin-3-gallate-induced inhibition of interleukin-6 release and adjustment of the regulatory T/T helper 17 cell balance in the treatment of colitis in mice.

Authors:  Zhenglei Xu; Cheng Wei; R U Zhang; Jun Yao; Dinguo Zhang; Lisheng Wang
Journal:  Exp Ther Med       Date:  2015-10-23       Impact factor: 2.447

10.  Balance of CD8+ CD28+ / CD8+ CD28- T lymphocytes is vital for patients with ulcerative colitis.

Authors:  Shi-Xue Dai; Gang Wu; Ying Zou; Yan-Ling Feng; Hong-Bo Liu; Jin-Shan Feng; Hong-Gang Chi; Ru-Xi Lv; Xue-Bao Zheng
Journal:  Dig Dis Sci       Date:  2012-08-01       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.